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Granulomatous amoebic encephalitis due to Acanthamoeba castellanii is a serious human infection with fatal
consequences, but it is not clear how the circulating amoebae interact with the blood-brain barrier and trans-
migrate into the central nervous system. We studied the effects of an Acanthamoeba encephalitis isolate be-
longing to the T1 genotype on human brain microvascular endothelial cells, which constitute the blood-brain
barrier. Using an apoptosis-specific enzyme-linked immunosorbent assay, we showed that Acanthamoe-
ba induces programmed cell death in brain microvascular endothelial cells. Next, we observed that Acantha-
moeba specifically activates phosphatidylinositol 3-kinase. Acanthamoeba-mediated brain endothelial cell death
was abolished using LY294002, a phosphatidylinositol 3-kinase inhibitor. These results were further confirmed
using brain microvascular endothelial cells expressing dominant negative forms of phosphatidylinositol 3-ki-
nase. This is the first demonstration that Acanthamoeba-mediated brain microvascular endothelial cell death
is dependent on phosphatidylinositol 3-kinase.
Acanthamoeba spp. are opportunistic protozoan parasites
that are widely distributed throughout the environment (12,
18). The genus Acanthamoeba consists of both pathogenic
and nonpathogenic species. Given the host susceptibility and
correct environmental conditions, Acanthamoeba can cause
granulomatous amoebic encephalitis (GAE), a fatal central
nervous system (CNS) infection that occurs in immunocom-
promised patients (7–10, 11, 19). Several lines of evidence
suggest that hematogenous spread is a prerequisite in Acan-
thamoeba encephalitis (19–21), but it is not clear how circulat-
ing amoebae cross the blood-brain barrier and gain access
to the CNS to produce disease. We have demonstrated that
pathogenic Acanthamoeba exhibits more than 60% binding to
human brain microvascular endothelial cells (HBMEC), which
constitute the blood-brain barrier (2). Acanthamoeba binding
to HBMEC is mediated by a mannose-binding protein ex-
pressed on the surface of Acanthamoeba cells (2). Moreover,
we showed that Acanthamoeba produces severe HBMEC cyto-
toxicity by secreting extracellular proteases, as well as using
contact-dependent mechanisms such as phagocytosis (12),
which may play an important role in blood-brain barrier per-
turbations. However, the host intracellular signaling pathways
and the molecular mechanisms associated with Acanthamoe-
ba-mediated HBMEC cytotoxicity have not been determined.
Lipid second messengers, such as those derived from the
polyphosphoinositide cycle, play a central role in many signal-
ing networks. The majority of inositol lipids reside in mem-
branes and serve as substrates for kinases, phosphatases, and
phospholipases. Phosphatidylinositol 3-kinases (PI3Ks) are im-
portant signaling molecules that phosphorylate the 3 OH po-
sition of the inositol ring of phosphoinositides (PIs), generat-
ing the second messengers PI(3)P, PI(3,4)P2, and PI(3,4,5)P3
(4, 17). These second messengers recruit the downstream ef-
fector molecules. More specifically, substrates with certain
FYVE domains (named after the first four proteins in this
motif, Fab1, YotB, Vac1p, and EEA1) bind PIP, and these
pathways have been implicated in vesicular trafficking or re-
ceptor-mediated endocytosis (5). In contrast, proteins contain-
ing pleckstrin homology (PH) domains bind PIP2 and PIP3 and
have been shown to have important cellular functions, includ-
ing cell proliferation, cell survival, cellular differentiation,
metabolism, and cytoskeletal rearrangements (17). How-
ever, most of the studies have been focused on growth hor-
mones, mitogenic cytokines, inflammatory cytokines, chemoat-
tractants, oncogenesis, or intracellular pathogens. In this study,
we determined HBMEC responses to the extracellular parasite
Acanthamoeba and the role of PI3K in Acanthamoeba-medi-
ated HBMEC death.
MATERIALS AND METHODS
All chemicals were purchased from Sigma Laboratories (Poole, Dorset,
United Kingdom) unless stated otherwise.
Acanthamoeba culture. Acanthamoeba castellanii ATCC 50494 was isolated
from a human brain necropsy from a patient who died of GAE, as previously
described (29). The genus Acanthamoeba is divided into 15 different genotypes
based on rRNA gene sequencing; the isolate used in the present study belongs to
the T1 genotype (12, 27). Acanthamoeba was routinely grown in PYG medium
(0.75% [wt/vol] proteose peptone, 0.75% [wt/vol] yeast extract, and 1.5% [wt/vol]
glucose) at 30°C in tissue culture flasks, and the medium was refreshed 17 to 20 h
prior to experiments as previously described (14). Unbound amoebae were
removed by several washes. The Acanthamoeba cells that remained bound to
flasks represented the trophozoite form and were used in all subsequent assays.
Human brain microvascular endothelial cell culture and transfection. Primary
brain microvascular endothelial cells were isolated from human tissue and cul-
tured as previously described (2, 30). Briefly, HBMEC were purified by fluores-
cence-activated cell sorting and tested for endothelial characteristics, such as
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expression of endothelial markers, F-VIII, carbonic anhydrase IV, and uptake of
acetylated low-density lipoprotein, which resulted in cultures that were more
than 99% pure. HBMEC were routinely grown on rat tail collagen-coated
dishes in RPMI 1640 containing 10% heat-inactivated fetal bovine serum, 10%
NuSerum, 2 mM glutamine, 1 mM pyruvate, penicillin (100 U/ml), streptomycin
(100 U/ml), nonessential amino acids, and vitamins (2, 30).
In some experiments, HBMEC were transfected with dominant negative mu-
tants with mutations in p110 (p110K) subunits of PI3K. The cDNAs of p110
mutants were cloned under the control of cytomegalovirus promoter with an
amino-terminal FLAG epitope tag in the eukaryotic expression vector pcDNA3,
which also conferred G418 resistance. The p110 construct was a kinase inactive
mutant, had a CAAX motif, and was constitutively translocated to the mem-
brane. HBMEC transfected with the expression vector pcDNA3 were used as
negative controls (Invitrogen, Paisley, United Kingdom). The pcDNA3 expres-
sion vectors with or without dominant negative p110 constructs were transfected
into the HBMEC using LipofectAMINE as previously described (15). Briefly, a
DNA-LipofectAMINE complex in RPMI 1640 was added to 50% confluent
HBMEC monolayers. After 6 h of incubation, the cells were washed and grown
in complete medium for 3 days, followed by selection with G418 (400 g/ml).
Antibiotic-resistant colonies were pooled and confirmed using Western blotting
assays (26).
Cytotoxicity assays. To determine the pathogenic potential of the Acantha-
moeba used in this study, cytotoxicity assays were performed as previously de-
scribed (13). Briefly, HBMEC were grown to monolayers in 24-well plates.
Acanthamoeba isolates (5  105 amoebae/well) were incubated with HBMEC
monolayers in serum-free medium (RPMI 1640 containing 2 mM glutamine,
1 mM pyruvate, and nonessential amino acids) at 37°C in 5% CO2 for 24 h. At
the end of this incubation period, supernatants were collected, and cytotoxicity
was determined by measuring lactate dehydrogenase (LDH) release (cytotoxicity
detection kit; Roche Applied Science, Lewes, East Sussex, United Kingdom).
Briefly, conditioned media of cocultures of Acanthamoeba and HBMEC were
collected, and the percentage of LDH was determined as follows: percentage of
cytotoxicity  (test value  control value/total amount of LDH released 
control value)  100). Control values were obtained from HBMEC incubated
alone, and the total amount of LDH released was measured with HBMEC
treated with 1% Triton X-100 for 1 h at 37°C.
Apoptosis assays. To determine the ability of Acanthamoeba to produce host
cell apoptosis using mouse monoclonal antibodies showing DNA and histone
fragmentation, an apoptosis-specific enzyme-linked immunosorbent assay
(ELISA) was performed according to the manufacturer’s instructions (Roche
Applied Science). This allowed specific determination of mono- and oligonu-
cleosomes in the cytoplasmic fraction of cell lysates. Briefly, HBMEC were
grown to monolayers in 96-well plates and incubated with 105 amoebae for 3 h
in serum-free medium at 37°C in 5% CO2. Following this, unbound parasites
were removed, and HBMEC with bound amoebae were lysed and centrifuged
(750  g, 10 min) to remove cellular debris according to the manufacturer’s
instructions. The apoptotic DNA fragments in the supernatants were determined
using anti-histone-biotin and anti-DNA-peroxidase antibodies. Antigen-antibody
complexes were collected using streptavidin-coated plates, followed by determi-
nation using the 2,2-azinobis(3-ethylbenzthiazolinesulfonic acid) (ABTS) sub-
strate. Finally, plates were read at 405 nm using 492 nm as a reference. HBMEC
incubated alone were used as negative controls, while HBMEC incubated with
etoposide (an apoptosis inducer) were used as positive controls. The percentage
of apoptosis was calculated as follows: percentage of apoptosis  (test value 
negative control value)  100. In some experiments, apoptosis assays were
performed in the presence of the selective PI3K inhibitor LY294002 [2-(4-
morpholinyl)-8-phenylchromone (2-morpholino-8-phenyl-4H-1-benzopyran-4-
one)].
Western blotting assays. Western blotting assays were performed to assess Akt
phosphorylation as previously described (15). Briefly, HBMEC were grown to
monolayers in 60-mm dishes, and cells were incubated with Acanthamoeba (5 
106 amoebae) for various times. Unbound amoebae were removed by several
washes, and cells were lysed with RIPA lysis buffer (50 mM Tris-HCl [pH 7.4],
0.1% sodium dodecyl sulfate, 0.5% Na deoxycholate, 10 mM Na pyrophosphate,
25 mM -glycerophosphate, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1%
Triton X-100, 1 mM Na3VO4, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride,
1 g/ml aprotonin, 1 g/ml leupeptin, 1 g/ml pepstatin). For immunoprecipi-
tation, equal amounts of cell lysates (500 g to 1 mg) were incubated with
primary monoclonal antibody against phospho-Akt residues (Cell Signaling
Tech, Beverly, MA) overnight at 4°C. Following this, 50 l of protein A agarose
beads (QIAGEN, Crawley, England) was added for 1 h to collect antigen-
antibody complexes. The immunocomplexes were washed three times and elec-
trophoresed using 10% sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis under denaturing conditions. Proteins were transferred onto nitrocellulose
membranes and blocked in 4% blocking buffer (blotting grade nonfat milk
solution; Bio-Rad, Hemel Hempstead, England). Membranes were blotted with
anti-phospho-Akt antibody in blocking buffer overnight at 4°C with gentle shak-
ing. On the next day, the membranes were washed and subsequently incubated
(60 min, 4°C) with horseradish peroxidase-linked secondary antibody. Protein
bands were visualized using an enhanced chemiluminescence detection kit (Am-
ersham Biosciences, Chalfont St. Giles, England).
RESULTS
Acanthamoeba GAE isolate belonging to the T1 genotype
exhibits severe HBMEC cytotoxicity. In this study, we used a
clinical isolate of Acanthamoeba from a GAE patient and de-
termined its effects on HBMEC, demonstrating the biological
relevance of Acanthamoeba interactions with the blood-brain
barrier (2, 12, 18). However, previous studies have shown that
long-term axenic cultivation of Acanthamoeba could result in
the loss of Acanthamoeba virulence (23). To determine the
pathogenic potential of the Acanthamoeba isolate used in this
study, cytotoxicity assays were performed. We determined that
the Acanthamoeba isolate belonging to the T1 genotype exhib-
ited more than 70% HBMEC cytotoxicity (Fig. 1), further
confirming its pathogenic potential. Acanthamoeba incubated
alone did not exhibit LDH release (Fig. 1).
GAE isolate belonging to the T1 genotype induces HBMEC
apoptosis. Acanthamoeba-mediated HBMEC cytotoxicity is a
result of degradation of intracellular constituents and the
buildup of toxins and toxic products of parasite metabolism,
ultimately leading to host cell death (1, 22). However, the
immediate effects of Acanthamoeba may involve cytokine re-
lease that leads to an inflammatory response (22), host cell
cycle arrest (29), or induction of apoptosis. Apoptosis or pro-
grammed cell death involves active participation of the host
cells regulated by intracellular signaling pathways (24, 25). For
a positive control, we tested various concentrations of etopo-
side (an apoptosis inducer) and determined that treatment
with a concentration of 15 M for 24 h induced maximum
HBMEC apoptosis; the apoptosis obtained with these values
was defined as 100% apoptosis. To determine the ability of
Acanthamoeba to induce HBMEC intracellular signaling path-
ways leading to programmed cell death, an apoptosis-specific
FIG. 1. Acanthamoeba encephalitis isolate belonging to the T1 ge-
notype exhibits severe HBMEC cytotoxicity. Acanthamoeba (5  105
amoebae) was added to confluent monolayers of HBMEC in 24-well
plates and incubated at 37°C for 24 h. After this, supernatants were
collected, and cytotoxicity was determined by measuring lactate dehy-
drogenase release as described in Materials and Methods. Endothelial
cells without parasites were used as negative controls. Acanthamoeba
exhibited more than 70% HBMEC cytotoxicity. The error bars indicate
standard deviations. The data represent three independent experi-
ments performed in triplicate.
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ELISA was used. We observed that Acanthamoeba induced up
to 70% HBMEC apoptosis within 3 h (Fig. 2). This is the first
study demonstrating that Acanthamoeba induces apoptosis in
HBMEC, implicating the role of host intracellular pathways in
the response to Acanthamoeba. Interestingly, formalin- and/or
acetone-fixed amoebae were unable to produce HBMEC apo-
ptosis and exhibited no binding to HBMEC or human corneal
epithelial cells (HCEC), indicating that live amoebae are re-
quired (data not shown).
Acanthamoeba induces PI3K activation in HBMEC. PI3K
molecules directly phosphorylate the 3 OH position of the
inositol ring of PIs, generating the second messengers PI(3)P,
PI(3,4)P2. and PI(3,4,5)P3(12,13). The 3-phosphorylated PIP2
and PIP3 bind to the PH domain of various substrates. Among
other effectors, Akt is a major downstream effector of PI3K.
Stimulation of PI3K results in Akt recruitment to the mem-
brane, and the Akt is subsequently phosphorylated at Thr308
by phosphoinositide-dependent kinase 1, followed by phos-
phorylation at Ser473 by phosphoinositide-dependent kinase 2,
resulting in enhanced activity. Therefore, we used Akt phos-
phorylation as an indicator of PI3K activation. To determine
whether Acanthamoeba activates PI3K, Western blotting as-
says were performed using anti-phospho-Akt for immunopre-
cipitation, followed by total Akt antibody for Western blotting
assays. We observed that coincubation of Acanthamoeba with
HBMEC resulted in Akt dephosphorylation within 15 min
(Fig. 3). A more-than-sixfold decrease in Akt phosphorylation
was observed (Fig. 3). HBMEC incubated alone for similar
times without serum exhibited no changes in Akt phosphory-
lation compared with the zero-time phosphorylation (data not
shown). Since Akt is well known to promote cell proliferation
and/or antiapoptotic effects, our results suggest that the initial
response of HBMEC to Acanthamoeba may inhibit cell sur-
vival pathways. However, further incubation of Acanthamoeba
with HBMEC resulted in stimulation of Akt phosphorylation
(a more-than-twofold increase) (Fig. 3). Interestingly, Akt
antibodies are specific to human Akt and did not react with
Acanthamoeba Akt (data not shown). Overall, these data indi-
cate that the HBMEC response to Acanthamoeba involves
PI3K-mediated signaling pathways.
Acanthamoeba-mediated HBMEC death is dependent on
PI3K activation. The finding described above that Acantha-
moeba dephosphorylates Akt within 15 min, which is followed
by increased Akt phosphorylation with longer incubation times
(Fig. 3), suggests the involvement of PI3K-mediated signaling
but does not clarify the role of PI3K in Acanthamoeba-medi-
ated HBMEC death. To precisely determine the role of PI3K
activation in Acanthamoeba-mediated HBMEC death, we used
the specific PI3K inhibitor LY294002. LY294002 selectively
binds to the ATP binding site of PI3K, thereby inhibiting its
catalytic activity, and has no inhibitory effect on other ATP-
requiring enzymes, such as protein kinase, lipid kinase, and
ATPase (32, 33). Apoptosis-specific ELISAs were performed
in the presence of LY294002. We observed that LY294002
significantly inhibited HBMEC death in a concentration-de-
pendent manner (Fig. 4) (P  0.05), indicating that Acantha-
moeba-induced HBMEC death is dependent on PI3K-medi-
ated pathways.
To further confirm the role of PI3K in Acanthamoeba-me-
FIG. 2. Acanthamoeba encephalitis isolate belonging to the T1 ge-
notype induces apoptosis in HBMEC. Acanthamoeba (105 amoebae/
well) was added to confluent monolayers of HBMEC in 96-well plates
and incubated at 37°C for 3 h. Following this, HBMEC were lysed, and
the supernatants were collected. The DNA fragments in the superna-
tants were determined with anti-histone-biotin and anti-DNA-peroxi-
dase antibodies using an apoptosis-specific ELISA as described in
Materials and Methods. Endothelial cells without parasites were used
as negative controls, while HBMEC incubated with etoposide (an
apoptosis inducer; 15 M) were used as positive controls. Treatment
with etoposide (15 M) for 24 h induced the maximum HBMEC
apoptosis, and the value obtained was defined as 100% apoptosis. The
percentage of apoptosis for test samples was calculated as follows:
percentage of apoptosis  (test value  negative control value)  100.
The error bars indicate standard deviations. The data represent three
independent experiments performed in triplicate.
FIG. 3. Acanthamoeba encephalitis isolate belonging to the T1 ge-
notype induces Akt phosphorylation in HBMEC. To determine wheth-
er Acanthamoeba activates PI3K, HBMEC were grown to monolayers
and then incubated with Acanthamoeba for various times. The cell
lysates were prepared and immunoprecipitated using phospho-Akt
antibodies (IP  phospo-Akt and IP  Akt), which was followed by
Western blotting with total Akt antibody (WB  Akt). The zero-time
lane contained HBMEC without Acanthamoeba. Note that Acantha-
moeba abolished Akt phosphorylation within 15 min. However, longer
incubation times resulted in stimulation of Akt phosphorylation, sug-
gesting that the HBMEC response to Acanthamoeba involves PI3K-
mediated signaling pathways. The results are representative of three
independent experiments.
FIG. 4. PI3K inhibitor blocksAcanthamoeba-induced HBMEC apo-
ptosis. To precisely determine the role of PI3K in Acanthamoeba-
mediated HBMEC death, apoptosis-specific ELISAs were performed
in the presence various concentrations of LY294002, a selective PI3K
inhibitor, as described in Materials and Methods. LY294002 inhibits
Acanthamoeba-induced apoptosis in a concentration-dependent man-
ner. The error bars indicate standard deviations. The data represent
three independent experiments performed in triplicate.
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diated host cell death, HBMEC were transfected with inactive
forms of catalytic PI3K subunit p110 (	PI3K). We observed
that Acanthamoeba produced significantly less cytotoxicity
in HBMEC expressing 	PI3K than in pcDNA3-transfected
HBMEC (Fig. 5). Taken together, these findings show for the
first time that Acanthamoeba-mediated HBMEC death is de-
pendent on the PI3K signaling pathway.
DISCUSSION
GAE due to Acanthamoeba is a serious infection that almost
always is fatal; however, the pathogenesis and pathophysiology
of Acanthamoeba encephalitis are not known. Several lines of
evidence suggest that hematogenous spread is a primary re-
quirement in GAE (19–21), but how circulating amoebae cross
the blood-brain barrier remains to be determined. We recently
isolated HBMEC, which constitute the blood-brain barrier,
and developed an in vitro model to study host-parasite inter-
actions. Previous studies using such models have focused on
intracellular pathogens, such as meningitis-causing bacteria.
For example, it has been shown that Escherichia coli K1 can
invade brain microvascular endothelial cells on the apical side,
traffic through the cytoplasm in a membrane-bound vacuole,
and exit on the basolateral side to produce meningitis without
affecting the blood-brain barrier function, as determined by
HBMEC monolayer integrity, HBMEC permeability, and high
electrical resistance (16, 28). In contrast, extracellular patho-
gens, such as Acanthamoeba, are unlikely to use similar mech-
anisms due to size limitations and must develop strategies to
produce blood-brain barrier perturbations to gain access to the
CNS to produce disease. In support of this, we show for the
first time that Acanthamoeba produces programmed cell death
in HBMEC. Findings of this study are of physiological rele-
vance as we used a clinical isolate of Acanthamoeba from a
deceased GAE patient. Moreover, our finding that Acantha-
moeba-mediated HBMEC death is dependent on PI3K activa-
tion is novel. Previous reports have extensively shown the role
of PI3K-mediated signaling in cell proliferation or antiapopto-
tic effects in an Akt-dependent fashion. For example, activated
PI3K phosphorylates the 3 OH position of the inositol ring of
PIs, generating the second messengers PIP2 and PIP3 (17).
These PI3K lipid products interact with proteins containing a
PH domain. Among other proteins, Akt is a major downstream
effector of PI3K that interacts with PIP2 or PIP3 through its PH
domain and is phosphorylated at residues Ser473 (carboxy-
terminal domain) and Thr308 (catalytic domain), resulting in
activated Akt kinase. Phosphorylated and activated Akt stim-
ulates cell proliferation or cytoprotective effects by modulating
the function of a variety of downstream molecules, including
BAD, caspase-9, CREB Forkhead, MDM2, NF-
B, cyclin D1,
and p53 (3, 6). Overall, these findings suggest that Akt-medi-
ated signaling pathways result in cell survival and/or cytopro-
tective effects. In support of this, our results show that Acan-
thamoeba interactions with HBMEC show a biphasic response.
First, we found that Acanthamoeba incubation resulted in
Akt dephosphorylation (inactivation) within 15 min. How-
ever, longer incubation of Acanthamoeba with HBMEC re-
sulted in a more-than-twofold increase in Akt phosphorylation.
This raises the question of why Acanthamoeba induces Akt
activation, which almost always results in cytoprotective effects.
One explanation is that Akt activation is a stress compensa-
tion response of HBMEC and may be independent of PI3K
activation. This may involve direct phosphorylation of Akt by
integrin-linked kinase 1 (35) or by Ca2/calmodulin-dependent
kinase kinase, leading to cell survival pathways (34). Additional
studies are needed to determine the precise role of Akt acti-
vation in response to Acanthamoeba.
To determine the role of PI3K in Acanthamoeba-mediated
HBMEC death, apoptosis assays were performed in the pres-
ence of LY294002, a selective PI3K inhibitor. We observed
that direct inhibition of PI3K significantly reduced Acantha-
moeba-mediated HBMEC death. This is somewhat surprising,
as PI3K-mediated signaling has been traditionally involved in
cell proliferation and cell survival effects. To further confirm
these findings, we used HBMEC expressing dominant negative
forms of PI3K and used for cytotoxicity assays. We observed
that Acanthamoeba exhibited significantly less cytotoxicity with
HBMEC expressing dominant negative forms of PI3K than
with HBMEC transfected with the vector alone. Overall, these
findings indicate that Acanthamoeba-mediated host cell death
is dependent on PI3K activation. In support of this, Thyrell et
al. (31) have shown that alpha interferon induces PI3K-medi-
ated apoptosis in myeloma cells without Akt phosphorylation.
It was further shown that downstream effectors of PI3K-medi-
ated apoptosis involve activation of the proapoptotic molecules
Bak and Bax, loss of mitochondrial membrane potential, and
release of cytochrome c, all well-known mediators of apoptosis.
Similar mechanisms may exist in Acanthamoeba-mediated host
cell death, and studies are in progress to address these issues.
In addition, previous studies have shown that Acanthamoeba
induces increased cytosolic free calcium, resulting in apoptosis
(1, 22); however, the relationships between calcium fluxes and
PI3K and whether pathways involving calcium fluxes and PI3K
are dependent or independent of each other remain to be de-
termined.
Other pathologies due to Acanthamoeba include sight-
threatening keratitis associated with severe pain due to radial
neuritis, inflammation with redness, and photophobia. We de-
termined whether Acanthamoeba uses similar signaling path-
ways to produce corneal epithelial cell death. For this, we used
a clinical isolate of Acanthamoeba from a keratitis patient
FIG. 5. HBMEC expressing dominant negative forms of PI3K are
less susceptible to Acanthamoeba-mediated cell death. HBMEC were
transfected with the eukaryotic expression vector pcDNA3 cloned
with mutant PI3K subunit p110 (	PI3K) or with the vector alone. The
HBMEC transfected with pcDNA3 or 	PI3K were used in Acantha-
moeba cytotoxicity assays as described in Materials and Methods. Note
that Acanthamoeba-mediated HBMEC death was significantly inhib-
ited in HBMEC expressing dominant negative PI3K. The error bars
indicate standard deviations. The data represent three independent
experiments performed in triplicate.
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belonging to the T4 genotype and determined its effects on
HCEC (29). Similar host responses were observed (data not
shown). More interestingly, Acanthamoeba (T4 isolate) abol-
ished HCEC Akt activation within 15 min of incubation, but
longer incubation times resulted in a more-than-sixfold in-
crease in Akt activation, a response similar to that of HBMEC
stimulated with T1 amoebae, clearly indicating that Acantha-
moeba induces similar mechanisms to produce host cell death.
These findings may have important clinical implications in
our search for drugs against infections due to Acanthamoeba.
Overall, these studies suggest that Acanthamoeba-mediated
HBMEC cytotoxic effects are dependent on PI3K signaling
pathways. A complete understanding of mechanisms associ-
ated with Acanthamoeba-mediated host cell death may help us
develop strategies to treat these serious infections.
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